Sage Therapeutics, Inc.

SAGE · NASDAQ
Analyze with AI
6/30/2025
3/31/2025
12/31/2024
9/30/2024
Assets
Cash & Equivalents$67,487$45,224$81,021$99,627
Short-Term Investments$298,085$378,630$423,397$469,527
Receivables$26,575$10,729$9,134$14,871
Inventory$0$0$0$0
Other Curr. Assets$16,938$19,893$17,749$20,962
Total Curr. Assets$409,085$454,476$531,301$604,987
Property Plant & Equip (Net)$10,631$11,135$11,643$12,270
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$1,450$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$1,756$4,058$4,278$5,175
Total NC Assets$13,837$15,193$15,921$17,445
Other Assets$0$0$0$0
Total Assets$422,922$469,669$547,222$622,432
Liabilities
Payables$692$5,435$12,699$7,126
Short-Term Debt$1,878$0$0$83
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$31,324$42,531$14,840$36,112
Total Curr. Liab.$44,642$49,778$71,615$60,406
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$9,543$10,043$10,518$10,191
Other Liabilities$0$0$0$0
Cap. Leases$11,421$11,855$11,836$10,274
Total Liabilities$54,185$59,821$82,133$70,597
Equity
Pref Stock$0$0$0$0
Common Stock$6$6$6$6
Retained Earnings-$3,082,191-$3,032,539-$2,970,325-$2,874,547
AOCI$15$142$244$901
Other Equity$0$3,442,239$0$0
Total Equity$368,737$409,848$465,089$551,835
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$422,922$469,669$547,222$622,432
Net Debt-$65,609-$45,224-$81,021-$99,544